Bio-Rad Levels Charges Against Zeiss

A dispute over rights to multiphoton fluorescence excitation has emerged between Carl Zeiss GmbH of Jena, Germany, and Bio-Rad Laboratories Inc. in Hertfordshire, UK.

Bio-Rad says it signed a worldwide exclusive license with Cornell University's research foundation in 1996 to commercialize and market the technology. Since then, it has worked with the Ithaca, N.Y., university to develop the technology.





LATEST NEWS

• HOLOEYE Partners with Fraunhofer IPMS on Microdisplay
  Nov 22, 2024
• PI Expands German Production Site: Week in Brief: 11/22/24
  Nov 22, 2024
• Lightsynq Emerges from Stealth with $18M Series A
  Nov 21, 2024
• REMBRANDT Project Collaborators to Advance Microwave Photonics
  Nov 21, 2024
• Quasicrystals Create Light Vortices to Transmit More Data with Fiber Optics
  Nov 21, 2024
• Study Finds Laser Light Can Cast a Shadow
  Nov 20, 2024
• Lumicell Adds CEO: People in the News: 11/20/24
  Nov 20, 2024
• AeroVironment to Acquire BlueHalo in $4.1B Transaction
  Nov 20, 2024